Biogen
BIIB
BIIB
1,018 hedge funds and large institutions have $51.5B invested in Biogen in 2017 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 389 increasing their positions, 395 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,018
Holders Change
-6
Holders Change %
-0.59%
% of All Funds
25.38%
Holding in Top 10
27
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-34.15%
% of All Funds
0.67%
New
90
Increased
389
Reduced
395
Closed
83
Calls
$808M
Puts
$1.07B
Net Calls
-$265M
Net Calls Change
-$42.8M
Top Buyers
| 1 |
BlackRock
New York
|
+$4.67B |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$356M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$354M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$345M |
| 5 |
Goldman Sachs
New York
|
+$121M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$727M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$466M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$336M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$164M |
| 5 |
Two Sigma Investments
New York
|
-$153M |
